Ketamine's Effects on Brain Connectivity in Depression
Author Information
Author(s): Tu Pei-Chi, Chang Wan-Chen, Su Tung-Ping, Lin Wei-Chen, Li Cheng-Ta, Bai Ya-Mei, Tsai Shih-Jen, Chen Mu-Hong
Primary Institution: Taipei Veterans General Hospital
Hypothesis
The rapid antidepressant and antisuicidal effects of ketamine are associated with changes in thalamocortical connectivity among patients with treatment-resistant depression.
Conclusion
Low-dose ketamine infusion alters thalamocortical connectivity, but these changes are not significantly associated with improvements in clinical symptoms.
Supporting Evidence
- Previous studies have shown an association between thalamocortical dysconnectivity and treatment-resistant depression.
- Ketamine has been shown to increase synaptogenesis and BDNF levels, leading to antidepressant effects.
- Functional connectivity changes were observed in the thalamus and frontal cortex after ketamine infusion.
Takeaway
This study looked at how ketamine affects brain connections in people with severe depression. It found that while ketamine changes how different parts of the brain talk to each other, it didn't clearly help with depression symptoms.
Methodology
Two randomized, double-blind, placebo-controlled trials were conducted with resting-state functional MRIs before and after ketamine infusion.
Potential Biases
Potential biases due to the small sample size and differences in illness severity between trial groups.
Limitations
The study's findings may be influenced by ongoing medications and the use of different placebos in the trials.
Participant Demographics
Patients with treatment-resistant depression, with varying ages and a history of suicidal ideation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website